Assertio Therapeutics Inc (ASRT) — Cash Flow-to-Debt Ratio
Assertio Therapeutics Inc (ASRT) has a Cash Flow-to-Debt Ratio of 0.06x as of March 2026, meaning its operating cash flow of $8.56 Million could theoretically repay 0% of its total liabilities ($135.67 Million) in one year. See Assertio Therapeutics Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Assertio Therapeutics Inc Cash Flow-to-Debt Ratio (1996–2025)
Historical debt coverage capacity for Assertio Therapeutics Inc across 30 annual periods. Also explore Assertio Therapeutics Inc equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Assertio Therapeutics Inc (1996–2025)
Year-by-year debt coverage analysis for Assertio Therapeutics Inc. For market capitalisation and broader financial context, see Assertio Therapeutics Inc (ASRT) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.16x | $-28.18 Million | $173.02 Million | ▼ -200.9% |
| 2024 | 0.16x | $26.41 Million | $163.65 Million | ▼ -51.7% |
| 2023 | 0.33x | $49.60 Million | $148.42 Million | ▼ -20.0% |
| 2022 | 0.42x | $78.60 Million | $188.19 Million | ▲ +1594.9% |
| 2021 | 0.02x | $5.52 Million | $224.13 Million | ▲ +109.3% |
| 2020 | -0.26x | $-65.57 Million | $247.76 Million | ▼ -237.3% |
| 2019 | 0.19x | $90.47 Million | $469.21 Million | ▲ +89.5% |
| 2018 | 0.10x | $72.50 Million | $712.53 Million | ▲ +42.2% |
| 2017 | 0.07x | $62.17 Million | $869.11 Million | ▲ +6.4% |
| 2016 | 0.07x | $65.50 Million | $974.55 Million | ▼ -51.0% |
| 2015 | 0.14x | $143.89 Million | $1.05 Billion | ▲ +185.1% |
| 2014 | -0.16x | $-55.92 Million | $346.62 Million | ▼ -714.0% |
| 2013 | 0.03x | $9.75 Million | $371.24 Million | ▲ +104.9% |
| 2012 | -0.54x | $-30.98 Million | $57.72 Million | ▼ -154.4% |
| 2011 | 0.99x | $57.65 Million | $58.45 Million | ▲ +2747.9% |
| 2010 | -0.04x | $-2.38 Million | $63.92 Million | ▼ -253.7% |
| 2009 | 0.02x | $1.84 Million | $75.86 Million | ▼ -55.2% |
| 2008 | 0.05x | $3.35 Million | $61.93 Million | ▼ -87.0% |
| 2007 | 0.42x | $14.66 Million | $35.12 Million | ▲ +220.4% |
| 2006 | -0.35x | $-27.70 Million | $79.91 Million | ▼ -171.7% |
| 2005 | 0.48x | $28.82 Million | $59.62 Million | ▲ +130.0% |
| 2004 | -1.61x | $-23.27 Million | $14.47 Million | ▲ +36.4% |
| 2003 | -2.53x | $-33.15 Million | $13.12 Million | ▼ -1585.4% |
| 2002 | -0.15x | $-4.44 Million | $29.59 Million | ▲ +87.6% |
| 2001 | -1.21x | $-12.40 Million | $10.22 Million | ▲ +24.4% |
| 2000 | -1.60x | $-6.65 Million | $4.15 Million | ▼ -437.5% |
| 1999 | -0.30x | $-3.94 Million | $13.22 Million | ▲ +86.9% |
| 1998 | -2.27x | $-2.50 Million | $1.10 Million | ▼ -3.3% |
| 1997 | -2.20x | $-1.10 Million | $500.00K | ▼ -285.0% |
| 1996 | -0.57x | $-400.00K | $700.00K | — |